These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8665882

  • 1. The effect of reversal of myoneural blockade on cerebrospinal fluid pressure following cerebral aneurysm surgery.
    Fawcett WJ, Chung RA, Fairley CJ, Hollway TE.
    Eur J Anaesthesiol; 1995 Nov; 12(6):591-5. PubMed ID: 8665882
    [Abstract] [Full Text] [Related]

  • 2. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O, White PF, Tufanogullari B, Klein K.
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [Abstract] [Full Text] [Related]

  • 3. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H, Toft P, Severinsen IK, May O.
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [Abstract] [Full Text] [Related]

  • 4. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
    Baurain MJ, Dernovoi BS, D'Hollander AA, Hennart DA, Cantraine FR.
    Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
    [Abstract] [Full Text] [Related]

  • 5. Reversal of vecuronium with neostigmine: a comparison between male and female patients.
    Saitoh Y, Aoki K, Okazaki M, Hirama T, Isosu T, Murakawa M.
    Fukushima J Med Sci; 2009 Dec; 55(2):61-70. PubMed ID: 20608096
    [Abstract] [Full Text] [Related]

  • 6. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
    Hayes A, Breslin D, Reid J, Mirakhur RK.
    Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
    [Abstract] [Full Text] [Related]

  • 7. Delayed reversal of a potentiated rocuronium neuromuscular block.
    Dubois PE.
    Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670
    [No Abstract] [Full Text] [Related]

  • 8. Reversal of vecuronium with neostigmine in patients with diabetes mellitus.
    Saitoh Y, Hattori H, Sanbe N, Nakajima H, Akatu M, Murakawa M.
    Anaesthesia; 2004 Aug; 59(8):750-4. PubMed ID: 15270964
    [Abstract] [Full Text] [Related]

  • 9. Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?
    Lien CA.
    Anesthesiology; 2010 Jan; 112(1):16-8. PubMed ID: 19952723
    [No Abstract] [Full Text] [Related]

  • 10. Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
    Kido K, Mizuta K, Mizuta F, Yasuda M, Igari T, Takahashi M.
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484
    [No Abstract] [Full Text] [Related]

  • 11. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT, Sprung J, Jankowski CJ.
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [Abstract] [Full Text] [Related]

  • 12. [Investigations into neostigmine-induced inhibition of neuromuscular transmission].
    Kitajima O, Suzuki T, Fukano N, Miyake E, Saeki S, Ogawa S.
    Masui; 2009 Apr; 58(4):410-5. PubMed ID: 19363999
    [Abstract] [Full Text] [Related]

  • 13. Recovery characteristics following antagonism of vecuronium with edrophonium, neostigmine or pyridostigmine.
    Yungbluth J, Henry JD, McAnallen K, Albee DT.
    AANA J; 1988 Apr; 56(2):127-33. PubMed ID: 2897148
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Myoneural conduction blockade by choline esters in the presence of cholinesterase inhibitors and restoration of conduction by cholinesterase reactivators].
    Protas LL.
    Dokl Akad Nauk SSSR; 1973 Apr 11; 209(5):1243-6. PubMed ID: 4350639
    [No Abstract] [Full Text] [Related]

  • 16. Preclinical pharmacology of sugammadex.
    Bom A, Hope F, Rutherford S, Thomson K.
    J Crit Care; 2009 Mar 11; 24(1):29-35. PubMed ID: 19272536
    [Abstract] [Full Text] [Related]

  • 17. Neuromuscular transmission: new concepts and agents.
    de Boer HD.
    J Crit Care; 2009 Mar 11; 24(1):36-42. PubMed ID: 19272537
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility to upper airway obstruction during partial neuromuscular block.
    D'Honneur G, Lofaso F, Drummond GB, Rimaniol JM, Aubineau JV, Harf A, Duvaldestin P.
    Anesthesiology; 1998 Feb 11; 88(2):371-8. PubMed ID: 9477058
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
    Lee C, Katz RL.
    J Crit Care; 2009 Mar 11; 24(1):43-9. PubMed ID: 19272538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.